Drug Shortage Report for JAMP AMOXI CLAV SUSPENSION
| Report ID | 246750 |
| Drug Identification Number | 02539411 |
| Brand name | JAMP AMOXI CLAV SUSPENSION |
| Common or Proper name | Amoxicillin and Clavulanate Potassium for Oral Suspension |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
| Strength(s) | 28.5MG 200MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 70 |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-23 |
| Estimated end date | 2025-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-03-18 | French | Compare |
| v3 | 2025-03-18 | English | Compare |
| v2 | 2025-01-04 | French | Compare |
| v1 | 2025-01-04 | English | Compare |
Showing 1 to 4 of 4